Curis Inc (CRIS)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$0.85-23.42%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · CRIS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -85.9% |
| Our one-year growth estimate | diamond | 26.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 111.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 66 industry peers
CRIS — capital allocation — Based in part upon the representations of the Purchasers in the Purchase
Dated 2026-10-19
Based in part upon the representations of the Purchasers in the Purchase Agreement, the offering and sale in the Offering of shares of Common Stock, Pre-Funded Warrants and Common Warrants (collectively, the “PIPE Securities”) is being conducted pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act. The PIPE Securities have not been registered under the Securities Act or any state securities laws, and the PIPE Securities may not be offered or sold in the Unite…
Why it matters: The fifth-patient update is tied to possible warrant cash. Curis linked that cash to its runway into the second half of 2027.
Supportive ifCuris reports dosing its fifth CLL patient by year-end 2026. It also reports proceeds from Series B warrant exercises.
Worry ifThe fifth patient is not dosed by year-end 2026, or the company reports no related warrant proceeds.
Why it matters: Curis reported $15.0 million in cash at March 31 and noted a need for more funding. New cash terms could change the runway picture.
Worry ifThe November 5 report gives cash below $15.0 million. It does not confirm more funding or enough cash to operate into the second half of 2027.
Less concerning ifThe report confirms funding for planned operations into the second half of 2027.
Why it matters: The October agreement covers 16.7 million shares or pre-funded warrants, plus other warrants. Final terms will show the added share supply and cash raised.
Watch forA filing confirms the offering closed. It states how much cash was raised and which securities were issued.
Also watch forA filing says the offering was canceled or reduced. It also may say the offering did not provide the stated securities or cash.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$382 on $10,000 · ±3.8% | How much price usually moves either way. |
| Bad day | $1,122 loss on $10,000 · 11.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,871 loss on $10,000 · 98.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.